Drug nonadherence prevalent in type 2 diabetes patients

07/25/2013 | InternalMedicineNews.com (free registration)

Research presented at the ADA 73rd Scientific Sessions showed the one-year drug discontinuation rate among type 2 diabetes patients was 89% in those taking a GLP-1 agonist, 82% in those who took a DPP-4 inhibitor and 84% in those treated with other diabetes drugs. The findings highlight the need for better persistence with GLP-1 agonist therapy, the lead researcher said.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR